Mucoepidermoid carcinoma was initially scripted in 1924. It is a definitive malignancy comprising of variable permutations of squamous cells, mucus-secreting cells and intermediate cells. A proportionate 35% of the major and minor salivary gland tumours are configured by the neoplasm and two-thirds of the lesions usually manifest in the parotid. Mucoepidermoid carcinoma may anomalously be situated in the breast, eustachian tube, pulmonary bronchi, thyroid, palate and occasionally in the sub-glottis. Females are frequently affected, contrary to the males, at an estimated ratio of 3:2. The tumours generally arise in the fifth decade of life, the emergence may extend from 15 years to 86 years. Although mucoepidermoid carcinoma is a common salivary gland malignancy in children. The neoplasm may also appear as a non-adnexal, non-melanocytic tumour and may exceptionally ensue in the skin. The non-adnexal neoplasm usually mimic the salivary gland counterparts.